Clinical Trial Associate

Website Codiak BioSciences

Engineering precision exosomes

Codiak Biosciences is a public, clinical stage company with a pipeline of first-in-class immuno-oncology assets based on a novel exosome platform. Other assets in development across the portfolio (and in partnerships) include exosome-based molecules in other disease areas (as well as vaccines). Codiak has two clinical stage assets of first-in-class exosome-based IO molecules in Phase I/II and a third IO molecule with planned IND end of 2021.

This role provides project support in the initiation, execution and close out of domestic and international clinical studies. The CTA has the responsibility to support the project teams to achieve quality results in a cost-effective and timely manner. Additionally, the incumbent will assist the Clinical Development team with establishing key practices and procedures.

To apply for this job please visit